Quest PharmaTech Inc. (TSXV:QPT)

Quest PharmaTech Cash Flow Statement

Financials in millions CAD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021	Jan 31, 2020
Net Income	-2.09	-3.02	-64.89	-85.04	190.06	-6.18
Depreciation & Amortization	-	0	0.01	0.04	0.04	0.04
Loss (Gain) From Sale of Assets	-	-	-0.09	57.75	-294.58	-
Asset Writedown & Restructuring Costs	-	-	-	0	0	-
Loss (Gain) From Sale of Investments	0.72	1.34	61.39	26.72	101.56	-
Loss (Gain) on Equity Investments	0.66	0.52	3.1	-	-	0.03
Stock-Based Compensation	0.14	0.47	0.15	0.27	0.45	1.43
Provision & Write-off of Bad Debts	0.1	0.1	-	-	-	-
Other Operating Activities	-0	-	-	-	-0	-7.45
Change in Accounts Receivable	-0.01	0.02	-0.22	0.03	-0.02	0
Change in Accounts Payable	-0.08	0.22	-0	0.02	-0	5.35
Change in Other Net Operating Assets	-0.02	0.01	-0	0.03	-0.03	0.4
Operating Cash Flow	-0.59	-0.34	-0.55	-0.17	-2.52	-6.38
Investment in Securities	-	-	-	-	0.3	2.81
Other Investing Activities	-	-	-0.01	-0.01	-0.04	-0.04
Investing Cash Flow	-	-	-0.01	-0.01	0.26	2.78
Short-Term Debt Issued	-	0.2	0.5	0.25	0.25	2.65
Total Debt Issued	-	0.2	0.5	0.25	0.25	2.65
Short-Term Debt Repaid	-	-0.2	-	-	-	-
Total Debt Repaid	-	-0.2	-	-	-	-
Net Debt Issued (Repaid)	-	-	0.5	0.25	0.25	2.65
Issuance of Common Stock	-	-	0.09	-	0.05	0.09
Other Financing Activities	0.68	0.68	0.09	-	-	2.66
Financing Cash Flow	0.68	0.68	0.68	0.25	0.3	5.4
Net Cash Flow	0.09	0.34	0.11	0.07	-1.95	1.81
Free Cash Flow	-0.59	-0.34	-0.55	-0.17	-2.52	-6.38
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.01	-0.04
Cash Interest Paid	-	-	0	0.01	0.01	0.01
Levered Free Cash Flow	-0.47	-0.02	-0.59	-0.11	-17.96	1.41
Unlevered Free Cash Flow	-0.45	-0	-0.58	-0.1	-17.95	1.42
Change in Net Working Capital	0.03	-0.34	0.23	-0.08	17.77	-8.46

Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.